Clinical Trial Update: Fluorescence Enhanced Stereotactic Surgery (FESS)

View source ↗

Summary

A clinical trial update indicates that a study evaluating fluorescence-enhanced stereotactic surgery for high-grade glioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: High Grade Glioma, High Grade Glioma (III or IV) | Status: RECRUITING